[1]
Pagano, L. et al. 2018. Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents. Acta Biomedica Atenei Parmensis. 89, 11-S (Dec. 2018), 5–39. DOI:https://doi.org/10.23750/abm.v89i11-S.7988.